PL EN
  1. www.sciencepharma.pl
  2. Aktualności
  3. EMA: This paper highlight s issues that require consideration during the development and lifecycle of coated nanomedicine products designed for parenteral administration

EMA: This paper highlight s issues that require consideration during the development and lifecycle of coated nanomedicine products designed for parenteral administration

22.08.2013
This paper highlights issues that require consideration during the development and lifecycle of coated nanomedicine products designed for parenteral administration.
Źródło wiadomośći: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/08/WC500147874.pdf

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny